Now a startup company named Celmatix is starting clinical trials for its technology, which aims to make the process more transparent and provide better therapies to women who want to get pregnant. The New York-based company combines genetic therapies with an ability to compute massive amounts of data to better predict the outcomes of various fertility treatments.
